What does IMVT company do? | Glauxie AI

Q: What does IMVT company do?

Immunovant, Inc. (IMVT) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Eric Venker. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody... Employees: 315.

Q: Who is the CEO of IMVT?

Find out who leads IMVT — CEO name, executive team, and compensation details.

Q: What sector is IMVT in?

Find IMVT sector, industry, and sub-industry classification with sector peer comparison.

Q: What are IMVT competitors?

Compare IMVT to its top competitors with side-by-side financials, valuation, and performance.

What does IMVT company do?

🦉

Immunovant, Inc. (IMVT)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOEric Venker

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in...

Key Executives

Name	Title
Andy Deig	Senior Vice President of Strategic Finance
Becky Merlina	Senior VP & Global Head of Quality
Christine Blodgett	Senior Vice President of Human Resources
Christopher Van Tuyl	Chief Legal Officer & Corporate Secretary
Eric Venker	Chief Executive Officer & Director
Frank Torti	Executive Chairperson of the Board

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

IMVT Profile Financials

Who is the CEO of IMVT? What sector is IMVT in? What are IMVT competitors?